17
Jul 2026
Professor Yasutoshi Kido of the Graduate School of Medicine, Osaka Metropolitan University (OMU), in collaboration with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) of the Democratic Republic of the Congo, is developing a portable rapid diagnostic system for Ebola virus disease (EVD) caused by Bundibugyo virus (BDBV).
17
Jul 2026
A laser-based technology being developed at Adelaide University could soon help authorities detect deadly counterfeit alcohol, expose wine fraud and even identify dangerous chemicals inside sealed bottles – all without opening them.
17
Jul 2026
A new study, using Mongolian gerbils as an animal model, demonstrated for the first time that trans-tympanic infrared laser stimulation of the cochlea evokes reliable, auditory-guided behaviour in awake animals without the need for genetic modification or invasive surgical implantation.
17
Jul 2026
AMT Medical B.V., a clinical-stage Dutch medical technology company, today announced that the one-year results of the SAFE-CAB II clinical trial have been published in The Journal of Thoracic and Cardiovascular Surgery.
17
Jul 2026
As of 14 July, 2,093 confirmed cases of Bundibugyo Virus Disease and 798 deaths had been reported in the DRC and Uganda. A total of 394 people have recovered.
17
Jul 2026
A study by the University of Barcelona has identified nearly 20 genes that could contribute to some people being more susceptible to depression, anxiety and traits such as irritability and neuroticism.
17
Jul 2026
Research from the BICYCLE study shows 4-year-olds born in lockdown excel in language but face challenges in executive function, indicating a need for support.
17
Jul 2026
A head-to-head trial of ADHD treatments finds dexamphetamine and methylphenidate equally effective, with notable differences in weight management over time.
17
Jul 2026
A study reveals dietary coaching aids weight loss equally in individuals with high and low genetic obesity risk, challenging genetic determinism in weight loss.
17
Jul 2026
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
